In contrast, semaglutide, liraglutide, and dulaglutide undergo proteolytic degradation with minimal renal clearance, making them suitable options for patients with renal impairment, though caution is still advised
Neumiller JJ, Campbell RK
This paper extends our current knowledge of the effectiveness of this class of medications. Weighing benefits and risks The greatest risk increases were seen for nausea and vomiting, kidney stones, gastroesophageal reflux disease or GERD, sleep disturbances and non-infectious gastroenteritis, which is inflammation of the digestive tract which can cause nausea, vomiting, diarrhea and stomach cramps
GLP-1 receptor agonists take center stage, tickling the brain's appetite regulation center in the hypothalamus and leaving it giggling with delight
Transdermal medications that actually work, like nicotine patches, use tiny molecules that can slip through the skin easily
McCarthy, Ewan R